Signal active
Investment Firm
Overview
Norwest is a venture capital and growth equity investment firm that specializes in venture and growth equity companies. Since its inception, it has invested in more than 600 companies and partnered with over 140 active companies across our venture and growth equity portfolio. The firm invests in early to late-stage companies across a wide range of sectors with a focus on consumer, enterprise, and healthcare. It offers a deep network of connections, operating experience, and a wide range of impactful services to help CEOs and founders scale their businesses.
Highlights
1961
Financial Services
251-500
931
364
201
Late Stage Venture, Early Stage Venture, Seed, Private Equity
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Norwest Venture Partners, established in 1961 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Financial Services, Advertising, Financial Exchanges, Venture Capital, Asset Management, Finance, Software, Blogging Platforms, Hardware, Search Engine. The organization boasts a portfolio of 930 investments, with an average round size of $45.9M and 201 successful exits. Their recent investments include Leader Ventures, Saints Capital, Trident Capital, Retrevo, Alloy Ventures. The highest investment round they participated in was $3006.2B. Among their most notable exits are Leader Ventures and Saints Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
931
119
364
201
Investments
931
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jun 27, 2024 | - | - | 4.0M |
Jul 08, 2024 | Courier Health | Health Care | 16.5M |
Jul 22, 2024 | Heeler | - | 8.5M |
Aug 05, 2024 | MBX Biosciences | Biotechnology | 63.5M |
Exits
201
Funding Timeline
931
0
14
Funding Rounds
931
Norwest Venture Partners has raised 931 rounds. Their latest funding was raised on Aug 05, 2024 from a Series C - MBX Biosciences round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jun 27, 2024 | Series A - VenoStent | - | 4.0M | - |
Jul 08, 2024 | Series A - Courier Health | - | 16.5M | - |
Jul 22, 2024 | Seed Round - Heeler | - | 8.5M | - |
Aug 05, 2024 | Series C - MBX Biosciences | - | 63.5M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.